HR 10629 · 93th Congress · Drug law and legislation

A bill to amend the Federal Food, Drug, and Cosmetic Act to establish a standard for determining substantial evidence of a drug's effectiveness for purposes of revocation of an approval of a new drug application under section 505 or repeal of a certification of antibiotics under section 507.

Introduced 1973-10-02· Sponsored by Rep. Carter, Tim Lee [R-KY-5]· House

Bill Progress

✓
Introduced
2
Committee
3
House Vote
4
Senate
5
Enacted
Latest: Referred to House Committee on Interstate and Foreign Commerce.(1973-10-02)

Plain Language Summary

[AI summary unavailable — showing source text] Establishes, under the Federal Food, Drug, and Cosmetic Act, a standard for determining substantial evidence of a drug's effectiveness for purposes of revocation of an approval of a new drug application under such Act, or repeal of a certification of antibiotics under such Act. (Amends 21 U.S.C. 355)…

Summarized by Claude AI · Non-partisan · For informational purposes only